The 5th Latin American Congress on Prehospital Emergencies (CLEP 2026) in Lima, Peru, brought together the world's leading minds and organizations in emergency medicine. Among the standout contributors was Amoul®, a global innovator in emergency care technology. Amoul®'s presence at CLEP 2026 wasn't just about showcasing products—it was about redefining the future of life-saving care. From advanced CPR to intelligent ventilators and multi-function defibrillators, Amoul®'s solutions empower first responders and medical professionals to save more lives, faster and safer.
CLEP 2026, hosted by CCES SALUD, served as a catalyst for knowledge exchange and clinical advancement. With participants from over 11 countries, the event created a dynamic environment for sharing breakthroughs in prehospital and emergency care. Amoul® stole the spotlight with its innovative portfolio, featuring the E8 Auto CPR, T500 Emergency Transport Turbine Ventilator, and i6 Defibrillator Monitor.
The Amoul® E8 Auto CPR device drew significant attention for its groundbreaking 3D technology. Unlike traditional CPR devices, the E8 harnesses both cardiac and thoracic pump mechanisms, delivering more effective compressions with minimal impact on the patient's chest. Its compliance with RTCA/DO-160G standards ensures safe usage during air ambulance operations, a critical factor for medical teams in remote or challenging environments. Wireless connectivity means the E8 is always ready when seconds count, giving first responders a crucial edge in cardiac emergencies.
Transporting critically ill patients requires reliability and adaptability. The T500 ventilator from Amoul® is engineered to meet these demands, offering powerful features that streamline complex emergency scenarios. Its versatility allows healthcare professionals to customize respiratory support for diverse patient needs, while its connectivity solutions integrate smoothly into existing healthcare systems. The result: enhanced patient safety and improved outcomes during the most vulnerable moments of transport.
The Amoul® i6 is more than just a defibrillator. It combines defibrillation, monitoring, pacing, and AED functions into a single, user-friendly device. With seamless switching between adult and pediatric settings, the i6 ensures healthcare providers are prepared for any cardiac emergency. Its intuitive interface allows rapid deployment, making every second count when lives hang in the balance.
CLEP 2026 was a melting pot of innovation, with Amoul®'s synchronized connectivity and 5G-enabled devices demonstrating the future of prehospital care. Real-time data transmission, advanced airway management, and integrated emergency protocols empower first responders to deliver more effective, life-saving interventions. Amoul®'s solutions not only improve on-the-scene care but also enhance the continuum of patient management, from the point of crisis through to definitive hospital treatment.
Amoul®'s commitment extends beyond technology—it's about collaboration and education. By partnering with international experts and local healthcare providers, Amoul® helps build capacity, elevate standards, and expand access to life-saving tools. Events like CLEP 2026 are crucial for fostering these partnerships, enabling the global emergency medicine community to learn, innovate, and grow together.
Amoul®'s showcase at CLEP 2026 was more than a product exhibition—it was a statement of intent. By delivering state-of-the-art emergency care solutions and driving international collaboration, Amoul® is shaping a future where emergency responders are empowered, patient outcomes are improved, and every second truly counts. As the world faces ever-evolving healthcare challenges, Amoul® stands committed to advancing technology, education, and care in prehospital and emergency medicine.